NCT03945812View on ClinicalTrials.gov

Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer

PHASE4CompletedINTERVENTIONAL
Enrollment

665

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

March 31, 2022

Study Completion Date

March 8, 2023

Conditions
InfertilityFrozen Embryo Transfer (FET)
Interventions
DRUG

Granulocyte Colony Stimulating Factor

Filgrastim, Amgen, California, USA 300 mg/1.0 mL

OTHER

Platelet Rich Plasma Arm

Platelet Rich Plasma Arm

OTHER

Saline

Saline 9%

Trial Locations (1)

Unknown

Hayat center, Maadi

All Listed Sponsors
collaborator

National Research Centre, Egypt

OTHER

lead

Wael Elbanna Clinic

OTHER

NCT03945812 - Platelet-Rich Plasma vs. Granulocyte Colony-Stimulating Factor vs. Placebo and Outcomes in Frozen Embryo Transfer | Biotech Hunter | Biotech Hunter